{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:29Z","timestamp":1792099889981,"version":"4.4.0"},"reference-count":140,"publisher":"The Korean Society for Transplantation","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.ctrjournal.org"],"crossmark-restriction":true},"short-container-title":["Clin Transplant Res"],"published-print":{"date-parts":[[2026,3,31]]},"DOI":"10.4285\/ctr.25.0060","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:52:08Z","timestamp":1767847928000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.4285\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Finerenone in kidney transplantation: an underinvestigated agent: review of available evidence, existing gaps, and future directions"],"prefix":"10.4285","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-7339","authenticated-orcid":false,"given":"Muhammad Abdul Mabood","family":"Khalil","sequence":"first","affiliation":[{"name":"Center of Renal Diseases and Transplantation, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1651-0528","authenticated-orcid":false,"given":"Nihal Mohammed","family":"Sadagah","sequence":"additional","affiliation":[{"name":"Center of Renal Diseases and Transplantation, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-1720","authenticated-orcid":false,"given":"Muhammad Shahab Uddin","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hayatabad Medical Complex Peshawar, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7370-4728","authenticated-orcid":false,"given":"Hideki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Organ Transplant Medicine, Tokyo Women\u2019s Medical University Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8176-9393","authenticated-orcid":false,"given":"Jackson","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9759-2200","authenticated-orcid":false,"given":"Salem H","family":"Al-Qurashi","sequence":"additional","affiliation":[{"name":"Center of Renal Diseases and Transplantation, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2819","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03686.x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01242.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000517358"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.09.003"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00010.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182336095"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V114753"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-009-0047-0"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20902.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000235527.81917.fe"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181caeead"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02006.x"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.06.025"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.001"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317424"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04488"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123992"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01312-9"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17406-0"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.01.025"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12210"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.352"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00123"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00077.2007"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043413"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000350539"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2956-1"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08526"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.016"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.110"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000118519.66430.22"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.118"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.101548"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.006"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00365.2015"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00512.2007"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22783"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00277.x"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000174593.88899.68"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.08.047"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.232"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10680"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90428.2008"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01131"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1159\/000524940"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1159\/000516213"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1159\/000518254"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v9.i6.123"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14609"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13180"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000439"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05300516"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.08.006"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308759200"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.02.003"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90721-0"},{"key":"ref59","unstructured":"Iacona A, Rossetti A, Filingeri V, Orsini D, Cesarini A, Cervelli V, et al. Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats. Drugs Exp Clin Res 1991;17:501-6."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00166.2005"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn204"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00707.x"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00147.2006"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/08860220801947397"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.11.025"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-42"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051373"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2012.01500.x"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.08.018"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab777"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04241-w"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-04142-1"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf125"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04512-3"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04381-w"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae132"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071928"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01944"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03060316"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070715"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04700513"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v7.i6.285"},{"key":"ref83","unstructured":"University of North Carolina. The effect of finerenone in kidney transplant recipients (EFFEKTOR). ClinicalTrials.gov [Internet]. 2024 [cited 2025 Jul 14]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06059664"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000360"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0505-6"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.131110"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2023.01.013"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05981"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41080"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000154365.30593.d3"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000258414.59393.89"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2891"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040477"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000091"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10360"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032536"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht187"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw132"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407107"},{"key":"ref100","unstructured":"Colorado Prevention Center. A study to determine the efficacy and safety of finerenone on morbidity and mortality among hospitalized heart failure patients (REDEFINE-HF). ClinicalTrials.gov [Internet]. 2023 [cited 2025 Jul 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06008197"},{"key":"ref101","unstructured":"Colorado Prevention Center. A study to evaluate finerenone on clinical efficacy and safety in patients with heart failure who are intolerant or not eligible for treatment with steroidal mineralocorticoid receptor antagonists (FINALITY-HF). ClinicalTrials.gov [Internet]. 2023 [cited 2025 Jul 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06033950"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.819327"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41746"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07666-x"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70065"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000090753.99170.89"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.043018"},{"key":"ref108","unstructured":"U.S. Food and Drug Administration (FDA). Kerendia (finerenone) prescribing information [Internet]. FDA; 2021 [cited 2025 Jul 18]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215341s000lbl.pdf"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443100-00001"},{"key":"ref110","unstructured":"European Medicines Agency (EMA). Kerendia: EPAR - product information [Internet]. EMA; 2023 [cited 2025 Jul 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kerendia-epar-product-information_en.pdf"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.317"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2021.100611"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001037"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab172"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.08.024"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153635"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00025.2019"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00606.2018"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00104.2021"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04161-9"},{"key":"ref121","unstructured":"Second Affiliated Hospital of Soochow University. Evaluation of the effect of finerenone on renal function in patients with type 2 diabetes and chronic kidney disease (KSD-01). ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06838416"},{"key":"ref122","unstructured":"Bayer. An observational study to learn more about how safe finerenone is and how well it works in Indian people with chronic kidney disease and type 2 diabetes in routine medical practice (IN-REALITY). ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06763146"},{"key":"ref123","unstructured":"Bayer. An observational study called FINEROD to learn more about the use of the treatment finerenone including how safe it is and how well it works under real-world conditions (FINEROD). ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06278207"},{"key":"ref124","unstructured":"Chinese University of Hong Kong. Use of clinical-trials and simulation models to estimate cost-effectiveness of non-steroidal mineralocorticoid antagonists, RASi and SGLT2i as triple therapy with type 2 diabetes and chronic kidney disease (RAiSiN). ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06727409"},{"key":"ref125","unstructured":"Bayer. An observational study called FIRST-2.0 to learn more about the use of the study treatment finerenone including how safe it is and how well it works under real-world conditions (FIRST-2). ClinicalTrials.gov [Internet]. 2024 [cited 2025 Aug 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05703880"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108411"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110908"},{"key":"ref128","unstructured":"Kotwal SS, Perkovic V, Jardine MJ, Kim D, Shah NA, Lin E, et al. The Global Kidney Patient Trials Network and the CAPTIVATE platform clinical trial design: a trial protocol. JAMA Netw Open 2024;7:e2449998."},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08021-z"},{"key":"ref130","unstructured":"Botkin Hospital. Finerenone in patients with IgA-nephropathy: prospective interventional trial. ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07056595"},{"key":"ref131","unstructured":"Zhejiang University. Effect of finerenone in IgA nephropathy (FIGHT). ClinicalTrials.gov [Internet]. 2024 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06580288"},{"key":"ref132","unstructured":"First Affiliated Hospital, Sun Yat-Sen University. Efficacy and safety of finerenone in patients with primary membranous nephropathy. ClinicalTrials.gov [Internet]. 2024 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06573411"},{"key":"ref133","unstructured":"University Hospital Goettingen. Alport Therapy Registry - European initiative towards delaying renal failure in Alport syndrome (Alport-XXL). ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02378805"},{"key":"ref134","unstructured":"National Institute for Health and Care Excellence (NICE). Finerenone for treating chronic kidney disease in type 2 diabetes [Internet]. NICE; 2023 [cited 2025 MM DD]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta877"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref136","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105(Suppl 4):S117-314."},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027"},{"key":"ref138","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of care in diabetes-2024. Diabetes Care 2024;47(Suppl 1):S179-218."},{"key":"ref139","unstructured":"Alexandria University. Effect of finerenone in patients with non-diabetic glomerulonephritis. ClinicalTrials.gov [Internet]. 2025 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06835322"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.03.015"}],"container-title":["Clinical Transplantation and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pdf.medrang.co.kr\/JKST\/2026\/040\/ctr-40-1-1.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"https:\/\/pdf.medrang.co.kr\/JKST\/2026\/040\/ctr-40-1-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:13:01Z","timestamp":1774509181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ctrjournal.org\/journal\/view.html?doi=10.4285\/ctr.25.0060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3,31]]}},"alternative-id":["10.4285\/ctr.25.0060"],"URL":"https:\/\/doi.org\/10.4285\/ctr.25.0060","relation":{},"ISSN":["3022-6783","3022-7712"],"issn-type":[{"value":"3022-6783","type":"print"},{"value":"3022-7712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"https:\/\/www.ctrjournal.org\/journal\/view.html?doi=10.4285\/ctr.25.0060","URL":"https:\/\/www.ctrjournal.org\/journal\/view.html?doi=10.4285\/ctr.25.0060","name":"the_journal","label":"Clin Transplant Res","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2025-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","order":3,"name":"published","label":"Online First","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-31","order":4,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2026 The Korean Society for Transplantation","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}